Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Fowler

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
Current Drug Targets. CNS and Neurological Disorders|December 27, 2005
Pharmacological properties and therapeutic possibilities for drugs acting upon endocannabinoid receptorsChristopher J Fowler
British Journal of Pharmacology|December 24, 2003
Oleamide: a member of the endocannabinoid family?Christopher J Fowler
Brain Research. Brain Research Reviews|December 31, 2002
Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents. Non-psychoactive cannabinoids, 'entourage' compounds and inhibitors of N-acyl ethanolamine breakdown as therapeutic strategies to avoid pyschotropic effectsChristopher J Fowler
Trends in Pharmacological Sciences|February 3, 2012
Anandamide uptake explained?Christopher J Fowler
Trends in Pharmacological Sciences|April 27, 2004
Possible involvement of the endocannabinoid system in the actions of three clinically used drugsChristopher J Fowler
Fundamental & Clinical Pharmacology|November 18, 2006
The cannabinoid system and its pharmacological manipulation--a review, with emphasis upon the uptake and hydrolysis of anandamideChristopher J Fowler
Current Pharmaceutical Design|September 11, 2008
"The tools of the trade"--an overview of the pharmacology of the endocannabinoid systemChristopher J Fowler
Trends in Pharmacological Sciences|June 6, 2012
NSAIDs: eNdocannabinoid stimulating anti-inflammatory drugs?Christopher J Fowler
The FEBS Journal|February 28, 2013
Transport of endocannabinoids across the plasma membrane and within the cellChristopher J Fowler
Molecular Neurobiology|October 24, 2007
The pharmacology of the cannabinoid system--a question of efficacy and selectivityChristopher J Fowler
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Current Drug Targets. CNS and Neurological Disorders|December 27, 2005
Pharmacological properties and therapeutic possibilities for drugs acting upon endocannabinoid receptorsChristopher J Fowler
British Journal of Pharmacology|December 24, 2003
Oleamide: a member of the endocannabinoid family?Christopher J Fowler
Brain Research. Brain Research Reviews|December 31, 2002
Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents. Non-psychoactive cannabinoids, 'entourage' compounds and inhibitors of N-acyl ethanolamine breakdown as therapeutic strategies to avoid pyschotropic effectsChristopher J Fowler
Trends in Pharmacological Sciences|February 3, 2012
Anandamide uptake explained?Christopher J Fowler
Trends in Pharmacological Sciences|April 27, 2004
Possible involvement of the endocannabinoid system in the actions of three clinically used drugsChristopher J Fowler
Fundamental & Clinical Pharmacology|November 18, 2006
The cannabinoid system and its pharmacological manipulation--a review, with emphasis upon the uptake and hydrolysis of anandamideChristopher J Fowler
Current Pharmaceutical Design|September 11, 2008
"The tools of the trade"--an overview of the pharmacology of the endocannabinoid systemChristopher J Fowler
Trends in Pharmacological Sciences|June 6, 2012
NSAIDs: eNdocannabinoid stimulating anti-inflammatory drugs?Christopher J Fowler
The FEBS Journal|February 28, 2013
Transport of endocannabinoids across the plasma membrane and within the cellChristopher J Fowler
Molecular Neurobiology|October 24, 2007
The pharmacology of the cannabinoid system--a question of efficacy and selectivityChristopher J Fowler
Pageof 17